{"id":"https://openalex.org/W4416626618","doi":"https://doi.org/10.1158/1078-0432.30706526","title":"Supplementary Figures1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas","display_name":"Supplementary Figures1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416626618","doi":"https://doi.org/10.1158/1078-0432.30706526"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30706526","doi":"https://doi.org/10.1158/1078-0432.30706526","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30706526","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30706526","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063504569","display_name":"Gerhard Jungwirth","orcid":"https://orcid.org/0000-0001-7571-8947","observed_orcids":["https://orcid.org/0000-0001-7571-8947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerhard Jungwirth","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7571-8947","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100401957","display_name":"Tao Yu","orcid":"https://orcid.org/0000-0001-7471-4290","observed_orcids":["https://orcid.org/0000-0001-7471-4290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tao Yu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7471-4290","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100453121","display_name":"Fang Liu","orcid":"https://orcid.org/0000-0003-2881-8114","observed_orcids":["https://orcid.org/0000-0003-2881-8114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fang Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2881-8114","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055005604","display_name":"Junguo Cao","orcid":"https://orcid.org/0000-0002-2254-8152","observed_orcids":["https://orcid.org/0000-0002-2254-8152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junguo Cao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2254-8152","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068781838","display_name":"Montadar Alaa Eddine","orcid":"https://orcid.org/0000-0001-5994-993X","observed_orcids":["https://orcid.org/0000-0001-5994-993X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Montadar Alaa Eddine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5994-993X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085166299","display_name":"Mahmoud Moustafa","orcid":"https://orcid.org/0000-0002-9146-0808","observed_orcids":["https://orcid.org/0000-0002-9146-0808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahmoud Moustafa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9146-0808","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075116222","display_name":"Amir Abdollahi","orcid":"https://orcid.org/0000-0002-8016-5897","observed_orcids":["https://orcid.org/0000-0002-8016-5897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amir Abdollahi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8016-5897","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014216255","display_name":"Rolf Warta","orcid":"https://orcid.org/0000-0003-2821-4361","observed_orcids":["https://orcid.org/0000-0003-2821-4361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rolf Warta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2821-4361","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014073957","display_name":"Andreas Wilhelm Unterberg","orcid":"https://orcid.org/0000-0003-3742-3288","observed_orcids":["https://orcid.org/0000-0003-3742-3288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Unterberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3742-3288","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025477516","display_name":"Christel C. Herold\u2010Mende","orcid":"https://orcid.org/0000-0002-1915-745X","observed_orcids":["https://orcid.org/0000-0002-1915-745X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christel Herold-Mende","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1915-745X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11251","display_name":"Meningioma and schwannoma management","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11251","display_name":"Meningioma and schwannoma management","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aggressive-meningioma","display_name":"aggressive meningioma","score":0.8050000071525574},{"id":"https://openalex.org/keywords/fda-approved-anticancer-drugs","display_name":"FDA-approved anticancer drugs","score":0.8040000200271606},{"id":"https://openalex.org/keywords/romidepsin","display_name":"romidepsin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/omacetaxine","display_name":"omacetaxine","score":0.8930000066757202},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.8069999814033508},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.7613000273704529},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7116000056266785},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44600000977516174},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3562999963760376},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3472000062465668},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.325300008058548},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.28220000863075256},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27810001373291016},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.2572999894618988},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.23409999907016754}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30706526","doi":"https://doi.org/10.1158/1078-0432.30706526","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30706526","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30706526","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures1_from_Pharmacological_Landscape_of_FDA-Approved_Anticancer_Drugs_Reveals_Sensitivities_to_Ixabepilone_Romidepsin_Omacetaxine_and_Carfilzomib_in_Aggressive_Meningiomas/30706526","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30706526","doi":"https://doi.org/10.1158/1078-0432.30706526","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30706526","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4307208518","https://openalex.org/W4361950516","https://openalex.org/W4404237131","https://openalex.org/W4240421015","https://openalex.org/W2983204265","https://openalex.org/W2028416174","https://openalex.org/W4403352180","https://openalex.org/W2007609542","https://openalex.org/W4237821920","https://openalex.org/W2039964553"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}